Impact of Quality Improvement Interventions on Biopsy-to-Treatment Time in Breast Cancer: Results from the PROMPT Quality Collaborative of the National Accreditation Program for Breast Centers
Authors:
- 9 August 2025
- journal article
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 32 (11) , 8256-8268
Abstract
To address the interval between biopsy and first treatment, the National Accreditation Program for Breast Centers (NAPBC) launched Patient-Reported Observations for Medical Procedure Timeliness (PROMPT), a quality collaborative. Participating PROMPT sites submitted data on the number of days from biopsy to first treatment (either surgery or neoadjuvant treatment (NAC)) before and after individual site-specific quality improvement (QI) projects using the American College of Surgeons Quality Framework. The study examined interventions of sites that reported successful projects and barriers for both successful and unsuccessful sites. Of 104 PROMPT sites, 62 (59.6 %) examined the time from biopsy to surgery, and 42 (40.4 %) analyzed the time from biopsy to NAC. Overall, 56 (53.8 %) sites decreased their interval from biopsy to treatment, from 50.3 to 38.8 days for biopsy to surgery and from 40.7 to 30.9 days for biopsy to NAC. No facility factors were associated with successfully decreasing this interval. The most common intervention for both intervals was enabling navigators to schedule appointments for surgeons and medical oncologists. Of 22 interventions for the interval from biopsy to surgery, the most common included hiring a breast surgeon and increasing operating room (OR) block time for surgeons. Of 17 interventions for the interval from biopsy to NAC, the most common were streamlining port-a-cath placements, ordering staging studies before seeing medical oncology, and offering concurrent medical oncology and surgery appointments. Just more than half of the PROMPT sites improved their interval. Interventions to improve timely care include hiring staff and improving scheduling.Keywords
Funding Information
- National Research Service Award (5TL1TR002388-07, 2TL1TR002388-06)
This publication has 14 references indexed in Scilit:
- Treatment intervals and survival for women diagnosed with early breast cancer in Queensland: the Breast Cancer Outcomes Study, a population‐based cohort studyMedical Journal of Australia, 2023
- Timeliness of Breast Diagnostic Imaging and Biopsy in Practice: 15 Years of Collecting, Comparing, and Defining Quality Breast Cancer CareAnnals of Surgical Oncology, 2023
- Time interval between breast cancer diagnosis and surgery is associated with disease outcomeScientific Reports, 2023
- Patient navigation across the cancer care continuum: An overview of systematic reviews and emerging literatureCA: A Cancer Journal for Clinicians, 2023
- Developing the American College of Surgeons Quality Improvement Framework to Evaluate Local Surgical Improvement EffortsJAMA Surgery, 2022
- A tool to predict disparities in the timeliness of surgical treatment for breast cancer patients in the USABreast Cancer Research and Treatment, 2022
- Time to Completion of Breast Cancer Treatment and SurvivalAnnals of Surgical Oncology, 2021
- Timing and Delays in Breast Cancer Evaluation and TreatmentAnnals of Surgical Oncology, 2018
- National Accreditation Program for Breast Centers Demonstrates Improved Compliance with Post-Mastectomy Radiation Therapy Quality MeasureJournal of the American College of Surgeons, 2017
- National quality validation programs for breast centersExpert Review of Anticancer Therapy, 2007